These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34004254)

  • 1. Comparative effects of incretin-based therapy on early-onset diabetic nephropathy in rats: Role of TNF-α, TGF-β and c-caspase-3.
    Habib HA; Heeba GH; Khalifa MMA
    Life Sci; 2021 Aug; 278():119624. PubMed ID: 34004254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combined therapy of mesenchymal stem cells with GLP-1 receptor agonist, exenatide, on early-onset nephropathy induced in diabetic rats.
    Habib HA; Heeba GH; Khalifa MMA
    Eur J Pharmacol; 2021 Feb; 892():173721. PubMed ID: 33159934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats.
    Maheshwari RA; Balaraman R; Sen AK; Seth AK
    Indian J Pharmacol; 2014; 46(6):627-32. PubMed ID: 25538335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats.
    Ahmed OM; Ali TM; Abdel Gaid MA; Elberry AA
    PLoS One; 2019; 14(9):e0214349. PubMed ID: 31527864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
    Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose lixisenatide protects against early-onset nephropathy induced in diabetic rats.
    Abdel-Latif RG; Ahmed AF; Heeba GH
    Life Sci; 2020 Dec; 263():118592. PubMed ID: 33065146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Black mulberry fruit extract alleviates streptozotocin-induced diabetic nephropathy in rats: targeting TNF-α inflammatory pathway.
    Abouzed TK; Sadek KM; Ghazy EW; Abdo W; Kassab MA; Hago S; Abdel-Wahab S; Mahrous EA; Abdel-Sattar E; Assar DH
    J Pharm Pharmacol; 2020 Nov; 72(11):1615-1628. PubMed ID: 32754951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetramethylpyrazine alleviates diabetic nephropathy through the activation of Akt signalling pathway in rats.
    Rai U; Kosuru R; Prakash S; Tiwari V; Singh S
    Eur J Pharmacol; 2019 Dec; 865():172763. PubMed ID: 31682792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal injury induced in alloxan diabetic rats. Role of Mycophenolate Mofetil as therapeutic agent.
    Elseweidy MM; Elswefy SE; Ali AE; Shawky M
    Pathol Res Pract; 2014 Dec; 210(12):979-84. PubMed ID: 24939145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Betanin, isolated from fruits of Opuntia elatior Mill attenuates renal fibrosis in diabetic rats through regulating oxidative stress and TGF-β pathway.
    Sutariya B; Saraf M
    J Ethnopharmacol; 2017 Feb; 198():432-443. PubMed ID: 28111218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
    Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats.
    Hofni A; El-Moselhy MA; Taye A; Khalifa MM
    Eur J Pharmacol; 2014 Dec; 744():173-82. PubMed ID: 25446917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sitagliptin ameliorates diabetic nephropathy by blocking TGF-β1/Smad signaling pathway.
    Wang D; Zhang G; Chen X; Wei T; Liu C; Chen C; Gong Y; Wei Q
    Int J Mol Med; 2018 May; 41(5):2784-2792. PubMed ID: 29484381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ellagic acid, an NF-κB inhibitor, ameliorates renal function in experimental diabetic nephropathy.
    Ahad A; Ganai AA; Mujeeb M; Siddiqui WA
    Chem Biol Interact; 2014 Aug; 219():64-75. PubMed ID: 24877639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway.
    Kuhad A; Chopra K
    Life Sci; 2009 Feb; 84(9-10):296-301. PubMed ID: 19162042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
    Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
    J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of levocetirizine and losartan on diabetic nephropathy and vascular dysfunction in streptozotocin-induced diabetic rats.
    Anbar HS; Shehatou GS; Suddek GM; Gameil NM
    Eur J Pharmacol; 2016 Jun; 780():82-92. PubMed ID: 27012991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril and Spironolactone Can Attenuate Diabetic Nephropathy in Wistar Rats by Targeting microRNA-192 and microRNA-29a/b/c.
    Ebadi Z; Moradi N; Kazemi Fard T; Balochnejadmojarrad T; Chamani E; Fadaei R; Fallah S
    DNA Cell Biol; 2019 Oct; 38(10):1134-1142. PubMed ID: 31433203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of concomitant administration of coenzyme Q10 with sitagliptin on experimentally induced diabetic nephropathy in rats.
    Maheshwari R; Balaraman R; Sen AK; Shukla D; Seth A
    Ren Fail; 2017 Nov; 39(1):130-139. PubMed ID: 27841100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Dipeptidyl Peptidase-IV Inhibitor Sitagliptin on Extracellular Signal-Regulated Kinases 1/2 Signaling in Rats with Diabetic Nephropathy.
    Ren X; Liu G; Wang Y; Zhang W; Xue F; Li R; Yu W
    Pharmacology; 2017; 100(1-2):1-13. PubMed ID: 28329747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.